Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Therapy
Sentinel node biopsy recommended before neoadjuvant chemotherapy
November 24th, 2005
Investigators recommended using sentinel node biopsy (SNB) before neoadjuvant chemotherapy for clinically node-negative breast cancer patients. According to recent research from the United States, "Because neoadjuvant chemotherapy is being used more frequently, the optimal timing of SNB remains controversial. We previously evaluated the predictive value of SNB before neoadjuvant chemotherapy in clinically node-negative breast cancer." "Our identification rate of the sentinel node among 52 patients before chemotherapy with a mean tumor size of 4 cm was 100%. In this study, we compared the identification rates of SNB before and after neoadjuvant...
Source: Women's Health Weekly (2005-11-24)
|
